5 PARK PLAZA, IRVINE, CA
Market cap: $12.3M (2/10/2026)
Price: $1.04
Reports BPD Type 2a Meeting with FDA and Shareholder Approval of the November Transactions
Investor Presentation
Announces Execution of Exchange Agreement with Daewoong
Reports Third Quarter 2025 Results, Including Positive ABP-450 Biosimilarity Data and Strategic Positioning for Continued Growth
AEON Biopharma Enters Into Securities Purchase Agreement with Investors
Earnings Release
Q3
Q2
Amended Quarterly Report
Amended Annual Report
Q1
FY 2024
FY 2023 amended
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Initial Statement of Beneficial Ownership
Schedule 13D - Ownership Report
Amended Schedule 13D - Ownership Report
Statement of Changes in Beneficial Ownership
Definitive Revised Proxy Statement